Trial NCT06643884
Suprachoroidal Administration in Subjects With Metastases to the Choroid
- Phase
- Phase 2
- Sponsor
- Aura Biosciences
- Conditions
- Eye Cancer; Primary Cancer
- Ages
- 18+ years
Eligibility criteria
Highlighted: restrictions our model extracted, each a verbatim quote (pink = excludes outright, blue = only under conditions).
Inclusion Criteria:
* Have a clinical diagnosis of Metastases to the Choroid, from a histopathologically or cytologically confirmed tumor.
* Have at least one Metastases to the Choroid in the study eye
Exclusion Criteria:
* Active ocular infection or disease.
* Must not have evidence of a primary tumor or metastatic lesion in the brain requiring treatment with radiation therapy where placement of the beam is likely to impact the study eye.Brain metastases
* Must not be planning or expecting to switch/add systemic antineoplastic therapies during treatment
Restrictions found (1)
- Brain metastasesConditionalexclusionShow in the text
Recruiting in Massachusetts
- Massachusetts Eye and Ear · Boston, Suffolk County